Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ursodeoxycholic Acid for Liver Regeneration After Donor Hepatectomy
NCT06091787Completed
- Sponsor
- Institute of Liver and Biliary Sciences
- Start
- Sep 2023
- Primary completion
- Nov 2024
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Randomised, open-label trial of ursodeoxycholic acid in Partial liver resection (2 arms), sponsored by Institute of Liver and Biliary Sciences. Primary endpoints: Regenerated liver volume at 14 days, Percentage of Total Liver Volume Restored at 14 days and 2 more. Started Sep 2023; status: completed.
02
Drugs
ursodeoxycholic acid
03
Conditions
Partial liver resection
Beyond the preview
Go deeper on NCT06091787.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06091787.